EMPA-PD: Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease (clinicaltrials.gov) - Sep 15, 2026 - P4 | N=22 | Active, not recruiting | Sponsor: Yale University | Recruiting ➔ Active, not recruiting
Enrollment closed • Chronic Kidney Disease • Nephrology • Renal Disease
|